Genetic or Pharmaceutical Blockade of Phosphoinositide 3-Kinase P110δ Prevents Chronic Rejection of Heart Allografts

• Huijun Ying ,

  Contributed equally to this work with: Huijun Ying, Hongmei Fu

  Affiliation Department of Immunology, Division of Medicine, Imperial College London, Hammersmith Campus, London, United Kingdom

  ⨯
• Hongmei Fu ,

  Contributed equally to this work with: Huijun Ying, Hongmei Fu

  Affiliation Department of Immunology, Division of Medicine, Imperial College London, Hammersmith Campus, London, United Kingdom

  ⨯
• Marlene L. Rose,

  Affiliation National Heart & Lung Institute, Division of Medicine, Imperial College London, Harefield Hospital, London, United Kingdom

  ⨯
• Ann M. McCormack,

  Affiliation National Heart & Lung Institute, Division of Medicine, Imperial College London, Harefield Hospital, London, United Kingdom

  ⨯
• Padmini Sarathchandra,

  Affiliation National Heart & Lung Institute, Division of Medicine, Imperial College London, Harefield Hospital, London, United Kingdom

  ⨯
• Klaus Okkenhaug,

  Affiliation Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom

  ⨯
• Federica M. Marelli-Berg

  * E-mail: f.marelli@imperial.ac.uk

  Current address: William Harvey Research Institute, Heart Centre, Charterhouse Square, London, United Kingdom

  Affiliation Department of Immunology, Division of Medicine, Imperial College London, Hammersmith Campus, London, United Kingdom

  ⨯